Global Contrast Enhanced Ultrasound Market to reach USD 2.37 billion by 2027.Global Contrast Enhanced Ultrasound Market is valued approximately USD 1.8 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4% % over the forecast period 2021-2027. Contrast-enhanced ultrasound (CEUS) is basically an application of ultrasound contrast medium in traditional medical sonography. In CEUS, the sound waves are reflected back from interfaces between substances such as air bubbles, blood or more complex structure. It is used to measure blood flow rate, monitor blood perfusion in different organs, and for various applications. Increasing number of chronic diseasesalso pushes the market of enhanced ultrasound market For Instance: as per the Journal of World Economic Forum, globally, one in three adult is suffering from two or more chronic illness condition i.e (MCC) .It also states that as the geriatric population increases the burden will continue to grow. Technological advancements in medical field boosts the contrast enhanced ultrasound market.However, complex nature of the procedure impedes the growth of the market over the forecast period of 2021-2027. Also, with the increasing extension of indication for use is likely to increase the market growth during the forecast period.

The regional analysis of global Contrast Enhanced Ultrasound Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to adoption of enhanced ultrasound technonlogy in abdominal and cardiac imaging .And for the study and research programs by sonologists and radiologists. Whereas,Asia-Pacific is also anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as increasing healthcare expenditure would create lucrative growth prospects for the Contrast Enhanced Ultrasound Market across Asia-Pacific region.

Major market player included in this report are:
Lantheus Medical Imaging, Inc.
Trivitron Healthcare
Acusphere,Inc
Koninklijke Philips N.V



Bracco Diagnostic, Inc.
General Electric
Siemens Healthcare GmbH
nanoPET Pharma GmbH
ESAOTE SPA
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByProduct:
Equipment
Contrast Agent
By Type:
Non-targeted
Targeted
By End-use:
Hospitals
Clinics
Ambulatory Diagnostic Centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Contrast Enhanced Ultrasound Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors